Thank you for the added note that it’s becoming more frequent for the FDA to fault the firm when they do not include interim controls when a final corrective and preventive action cannot be implemented immediately.
Enforcement last week included a collection of warning letters including three device warning letters and three drug GMP warning letters. And, warning letters to firms touting treatments for the coronavirus disease finally started appearing.
https://t.co/Yak58c57sH
Join me at the RAPS 2019 IVDR Pre-Conference Workshop on Sept. 21st in Philadelphia. Early registration til Friday 28 June 2019 https://t.co/Mj9YZKltRN
RAPS 2019 Sept. 21 workshop:Moving Beyond IVDR Req's to Fulfillment
How do you move beyond knowing what the IVDR requirements are to how to fulfill them? New concepts apply. ~90% of IVDs currently on EU market have not been scrutinized by a Notified Body, this is a new experience
Erik, thanks for keeping this up front for MD to see...
Bottleneck of bottlenecks for notified body capacity https://t.co/WPeNpX2ydo via @erikvollebregt